CONSULTING AGREEMENTConsulting Agreement • August 29th, 2024 • Karyopharm Therapeutics Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledAugust 29th, 2024 Company Industry JurisdictionThis Consulting Agreement (the “Agreement”), effective as of the Effective Date (as defined herein), is entered into between Karyopharm Therapeutics Inc. (the “Company”) and Michael Mason (the “Consultant”). The Consultant and the Company are referred to in this Agreement individually as a “Party” and collectively as the “Parties”.
CONSULTING AGREEMENTConsulting Agreement • May 5th, 2022 • Karyopharm Therapeutics Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledMay 5th, 2022 Company Industry JurisdictionThis Consulting Agreement (the “Agreement”), effective as of the Effective Date (as defined herein), is entered into between Karyopharm Therapeutics Inc. (the “Company”) and Jatin Shah, M.D. (the “Consultant”). The Consultant and the Company are referred to in this Agreement individually as a “Party” and collectively as the “Parties”.
CONSULTING AGREEMENTConsulting Agreement • September 25th, 2020 • Karyopharm Therapeutics Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledSeptember 25th, 2020 Company Industry JurisdictionThis Consulting Agreement (the “Agreement”), effective as of the Effective Date (as defined herein), is entered into between Karyopharm Therapeutics Inc. (the “Company”) and Christopher B. Primiano (the “Consultant”). The Consultant and the Company are referred to in this Agreement individually as a “Party” and collectively as the “Parties”.